The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/23085

Title:	The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.
Authors:	BIELEN, Rob Van Vlierberghe, H. Bourgeois, S. Moreno, C. Vanwollegem, T. Verlinden, W. Mulkay, J.P. Decaestecker, J. Cool, M. de Galocsy, C. Van Overbeke, L. Janssens, F. Van Steenkiste, C. Wuyckens, K. Nevens, F. ROBAEYS, Geert
Issue Date:	2017
Source:	Belgian week of Gastroenterology, XXIXth edition, Hilton Hotel, Antwerp, Belgium, 9-11/02/2017
Document URI:	http://hdl.handle.net/1942/23085
Category:	C2
Type:	Conference Material
Appears in Collections:	Research publications

52

checked on Jun 22, 2022

Check